Market Intelligence chevron_right Medical Care chevron_right Prostate-specific Antigen (PSA) Testing
Global Report 2021

Global Prostate-specific Antigen (PSA) Testing Market Size, Status and Forecast 2024-2031

calendar_todayPublished: Dec 2021 descriptionPages: 115 categoryCategory: Medical Care
cloud_downloadRequest Sample Report
mailPre-Order Enquiry
local_offerGet Discount 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Prostate-specific Antigen (PSA) Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 CLIA Method
        1.2.3 ELISA Method
    1.3 Market by Application
        1.3.1 Global Prostate-specific Antigen (PSA) Testing Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Screening
        1.3.3 Post-treatment Monitoring
        1.3.4 Other
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Prostate-specific Antigen (PSA) Testing Market Perspective (2016-2027)
    2.2 Prostate-specific Antigen (PSA) Testing Growth Trends by Regions
        2.2.1 Prostate-specific Antigen (PSA) Testing Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Prostate-specific Antigen (PSA) Testing Historic Market Share by Regions (2016-2021)
        2.2.3 Prostate-specific Antigen (PSA) Testing Forecasted Market Size by Regions (2022-2027)
    2.3 Prostate-specific Antigen (PSA) Testing Industry Dynamic
        2.3.1 Prostate-specific Antigen (PSA) Testing Market Trends
        2.3.2 Prostate-specific Antigen (PSA) Testing Market Drivers
        2.3.3 Prostate-specific Antigen (PSA) Testing Market Challenges
        2.3.4 Prostate-specific Antigen (PSA) Testing Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Prostate-specific Antigen (PSA) Testing Players by Revenue
        3.1.1 Global Top Prostate-specific Antigen (PSA) Testing Players by Revenue (2016-2021)
        3.1.2 Global Prostate-specific Antigen (PSA) Testing Revenue Market Share by Players (2016-2021)
    3.2 Global Prostate-specific Antigen (PSA) Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Prostate-specific Antigen (PSA) Testing Revenue
    3.4 Global Prostate-specific Antigen (PSA) Testing Market Concentration Ratio
        3.4.1 Global Prostate-specific Antigen (PSA) Testing Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Prostate-specific Antigen (PSA) Testing Revenue in 2020
    3.5 Prostate-specific Antigen (PSA) Testing Key Players Head office and Area Served
    3.6 Key Players Prostate-specific Antigen (PSA) Testing Product Solution and Service
    3.7 Date of Enter into Prostate-specific Antigen (PSA) Testing Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Prostate-specific Antigen (PSA) Testing Breakdown Data by Type
    4.1 Global Prostate-specific Antigen (PSA) Testing Historic Market Size by Type (2016-2021)
    4.2 Global Prostate-specific Antigen (PSA) Testing Forecasted Market Size by Type (2022-2027)

5 Prostate-specific Antigen (PSA) Testing Breakdown Data by Application
    5.1 Global Prostate-specific Antigen (PSA) Testing Historic Market Size by Application (2016-2021)
    5.2 Global Prostate-specific Antigen (PSA) Testing Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Prostate-specific Antigen (PSA) Testing Market Size (2016-2027)
    6.2 North America Prostate-specific Antigen (PSA) Testing Market Size by Type
        6.2.1 North America Prostate-specific Antigen (PSA) Testing Market Size by Type (2016-2021)
        6.2.2 North America Prostate-specific Antigen (PSA) Testing Market Size by Type (2022-2027)
        6.2.3 North America Prostate-specific Antigen (PSA) Testing Market Size by Type (2016-2027)
    6.3 North America Prostate-specific Antigen (PSA) Testing Market Size by Application
        6.3.1 North America Prostate-specific Antigen (PSA) Testing Market Size by Application (2016-2021)
        6.3.2 North America Prostate-specific Antigen (PSA) Testing Market Size by Application (2022-2027)
        6.3.3 North America Prostate-specific Antigen (PSA) Testing Market Size by Application (2016-2027)
    6.4 North America Prostate-specific Antigen (PSA) Testing Market Size by Country
        6.4.1 North America Prostate-specific Antigen (PSA) Testing Market Size by Country (2016-2021)
        6.4.2 North America Prostate-specific Antigen (PSA) Testing Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Prostate-specific Antigen (PSA) Testing Market Size (2016-2027)
    7.2 Europe Prostate-specific Antigen (PSA) Testing Market Size by Type
        7.2.1 Europe Prostate-specific Antigen (PSA) Testing Market Size by Type (2016-2021)
        7.2.2 Europe Prostate-specific Antigen (PSA) Testing Market Size by Type (2022-2027)
        7.2.3 Europe Prostate-specific Antigen (PSA) Testing Market Size by Type (2016-2027)
    7.3 Europe Prostate-specific Antigen (PSA) Testing Market Size by Application
        7.3.1 Europe Prostate-specific Antigen (PSA) Testing Market Size by Application (2016-2021)
        7.3.2 Europe Prostate-specific Antigen (PSA) Testing Market Size by Application (2022-2027)
        7.3.3 Europe Prostate-specific Antigen (PSA) Testing Market Size by Application (2016-2027)
    7.4 Europe Prostate-specific Antigen (PSA) Testing Market Size by Country
        7.4.1 Europe Prostate-specific Antigen (PSA) Testing Market Size by Country (2016-2021)
        7.4.2 Europe Prostate-specific Antigen (PSA) Testing Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Size (2016-2027)
    8.2 Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Size by Type
        8.2.1 Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Size by Type (2016-2027)
    8.3 Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Size by Application
        8.3.1 Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Size by Application (2016-2027)
    8.4 Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Size by Region
        8.4.1 Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Prostate-specific Antigen (PSA) Testing Market Size (2016-2027)
    9.2 Latin America Prostate-specific Antigen (PSA) Testing Market Size by Type
        9.2.1 Latin America Prostate-specific Antigen (PSA) Testing Market Size by Type (2016-2021)
        9.2.2 Latin America Prostate-specific Antigen (PSA) Testing Market Size by Type (2022-2027)
        9.2.3 Latin America Prostate-specific Antigen (PSA) Testing Market Size by Type (2016-2027)
    9.3 Latin America Prostate-specific Antigen (PSA) Testing Market Size by Application
        9.3.1 Latin America Prostate-specific Antigen (PSA) Testing Market Size by Application (2016-2021)
        9.3.2 Latin America Prostate-specific Antigen (PSA) Testing Market Size by Application (2022-2027)
        9.3.3 Latin America Prostate-specific Antigen (PSA) Testing Market Size by Application (2016-2027)
    9.4 Latin America Prostate-specific Antigen (PSA) Testing Market Size by Country
        9.4.1 Latin America Prostate-specific Antigen (PSA) Testing Market Size by Country (2016-2021)
        9.4.2 Latin America Prostate-specific Antigen (PSA) Testing Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size (2016-2027)
    10.2 Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size by Type
        10.2.1 Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size by Type (2016-2027)
    10.3 Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size by Application
        10.3.1 Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size by Application (2016-2027)
    10.4 Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size by Country
        10.4.1 Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Abbott
        11.1.1 Abbott Company Details
        11.1.2 Abbott Business Overview
        11.1.3 Abbott Prostate-specific Antigen (PSA) Testing Introduction
        11.1.4 Abbott Revenue in Prostate-specific Antigen (PSA) Testing Business (2016-2021)
        11.1.5 Abbott Recent Development
    11.2 Boston Scientific Corporation
        11.2.1 Boston Scientific Corporation Company Details
        11.2.2 Boston Scientific Corporation Business Overview
        11.2.3 Boston Scientific Corporation Prostate-specific Antigen (PSA) Testing Introduction
        11.2.4 Boston Scientific Corporation Revenue in Prostate-specific Antigen (PSA) Testing Business (2016-2021)
        11.2.5 Boston Scientific Corporation Recent Development
    11.3 Bayer AG
        11.3.1 Bayer AG Company Details
        11.3.2 Bayer AG Business Overview
        11.3.3 Bayer AG Prostate-specific Antigen (PSA) Testing Introduction
        11.3.4 Bayer AG Revenue in Prostate-specific Antigen (PSA) Testing Business (2016-2021)
        11.3.5 Bayer AG Recent Development
    11.4 Siemens Healthcare
        11.4.1 Siemens Healthcare Company Details
        11.4.2 Siemens Healthcare Business Overview
        11.4.3 Siemens Healthcare Prostate-specific Antigen (PSA) Testing Introduction
        11.4.4 Siemens Healthcare Revenue in Prostate-specific Antigen (PSA) Testing Business (2016-2021)
        11.4.5 Siemens Healthcare Recent Development
    11.5 DiaSorin
        11.5.1 DiaSorin Company Details
        11.5.2 DiaSorin Business Overview
        11.5.3 DiaSorin Prostate-specific Antigen (PSA) Testing Introduction
        11.5.4 DiaSorin Revenue in Prostate-specific Antigen (PSA) Testing Business (2016-2021)
        11.5.5 DiaSorin Recent Development
    11.6 Roche
        11.6.1 Roche Company Details
        11.6.2 Roche Business Overview
        11.6.3 Roche Prostate-specific Antigen (PSA) Testing Introduction
        11.6.4 Roche Revenue in Prostate-specific Antigen (PSA) Testing Business (2016-2021)
        11.6.5 Roche Recent Development
    11.7 Beckman Coulter
        11.7.1 Beckman Coulter Company Details
        11.7.2 Beckman Coulter Business Overview
        11.7.3 Beckman Coulter Prostate-specific Antigen (PSA) Testing Introduction
        11.7.4 Beckman Coulter Revenue in Prostate-specific Antigen (PSA) Testing Business (2016-2021)
        11.7.5 Beckman Coulter Recent Development
    11.8 PerkinElmer
        11.8.1 PerkinElmer Company Details
        11.8.2 PerkinElmer Business Overview
        11.8.3 PerkinElmer Prostate-specific Antigen (PSA) Testing Introduction
        11.8.4 PerkinElmer Revenue in Prostate-specific Antigen (PSA) Testing Business (2016-2021)
        11.8.5 PerkinElmer Recent Development
    11.9 Tosoh
        11.9.1 Tosoh Company Details
        11.9.2 Tosoh Business Overview
        11.9.3 Tosoh Prostate-specific Antigen (PSA) Testing Introduction
        11.9.4 Tosoh Revenue in Prostate-specific Antigen (PSA) Testing Business (2016-2021)
        11.9.5 Tosoh Recent Development
    11.10 Ortho Clinical
        11.10.1 Ortho Clinical Company Details
        11.10.2 Ortho Clinical Business Overview
        11.10.3 Ortho Clinical Prostate-specific Antigen (PSA) Testing Introduction
        11.10.4 Ortho Clinical Revenue in Prostate-specific Antigen (PSA) Testing Business (2016-2021)
        11.10.5 Ortho Clinical Recent Development
    11.11 Fujirebio
        11.11.1 Fujirebio Company Details
        11.11.2 Fujirebio Business Overview
        11.11.3 Fujirebio Prostate-specific Antigen (PSA) Testing Introduction
        11.11.4 Fujirebio Revenue in Prostate-specific Antigen (PSA) Testing Business (2016-2021)
        11.11.5 Fujirebio Recent Development
    11.12 Mediwatch
        11.12.1 Mediwatch Company Details
        11.12.2 Mediwatch Business Overview
        11.12.3 Mediwatch Prostate-specific Antigen (PSA) Testing Introduction
        11.12.4 Mediwatch Revenue in Prostate-specific Antigen (PSA) Testing Business (2016-2021)
        11.12.5 Mediwatch Recent Development
    11.13 BodiTech
        11.13.1 BodiTech Company Details
        11.13.2 BodiTech Business Overview
        11.13.3 BodiTech Prostate-specific Antigen (PSA) Testing Introduction
        11.13.4 BodiTech Revenue in Prostate-specific Antigen (PSA) Testing Business (2016-2021)
        11.13.5 BodiTech Recent Development
    11.14 Bristol-Myers Squibb Company
        11.14.1 Bristol-Myers Squibb Company Company Details
        11.14.2 Bristol-Myers Squibb Company Business Overview
        11.14.3 Bristol-Myers Squibb Company Prostate-specific Antigen (PSA) Testing Introduction
        11.14.4 Bristol-Myers Squibb Company Revenue in Prostate-specific Antigen (PSA) Testing Business (2016-2021)
        11.14.5 Bristol-Myers Squibb Company Recent Development
    11.15 GE Healthcare
        11.15.1 GE Healthcare Company Details
        11.15.2 GE Healthcare Business Overview
        11.15.3 GE Healthcare Prostate-specific Antigen (PSA) Testing Introduction
        11.15.4 GE Healthcare Revenue in Prostate-specific Antigen (PSA) Testing Business (2016-2021)
        11.15.5 GE Healthcare Recent Development
    11.16 Endocare
        11.16.1 Endocare Company Details
        11.16.2 Endocare Business Overview
        11.16.3 Endocare Prostate-specific Antigen (PSA) Testing Introduction
        11.16.4 Endocare Revenue in Prostate-specific Antigen (PSA) Testing Business (2016-2021)
        11.16.5 Endocare Recent Development
    11.17 Merck＆Co.
        11.17.1 Merck＆Co. Company Details
        11.17.2 Merck＆Co. Business Overview
        11.17.3 Merck＆Co. Prostate-specific Antigen (PSA) Testing Introduction
        11.17.4 Merck＆Co. Revenue in Prostate-specific Antigen (PSA) Testing Business (2016-2021)
        11.17.5 Merck＆Co. Recent Development
    11.18 Medtronic
        11.18.1 Medtronic Company Details
        11.18.2 Medtronic Business Overview
        11.18.3 Medtronic Prostate-specific Antigen (PSA) Testing Introduction
        11.18.4 Medtronic Revenue in Prostate-specific Antigen (PSA) Testing Business (2016-2021)
        11.18.5 Medtronic Recent Development
    11.18 Sanofi-Aventis SA
        .1 Sanofi-Aventis SA Company Details
        .2 Sanofi-Aventis SA Business Overview
        .3 Sanofi-Aventis SA Prostate-specific Antigen (PSA) Testing Introduction
        .4 Sanofi-Aventis SA Revenue in Prostate-specific Antigen (PSA) Testing Business (2016-2021)
        .5 Sanofi-Aventis SA Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Prostate-specific Antigen (PSA) Testing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of CLIA Method
    Table 3. Key Players of ELISA Method
    Table 4. Global Prostate-specific Antigen (PSA) Testing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 5. Global Prostate-specific Antigen (PSA) Testing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Prostate-specific Antigen (PSA) Testing Market Size by Regions (2016-2021) & (US$ Million)
    Table 7. Global Prostate-specific Antigen (PSA) Testing Market Share by Regions (2016-2021)
    Table 8. Global Prostate-specific Antigen (PSA) Testing Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 9. Global Prostate-specific Antigen (PSA) Testing Market Share by Regions (2022-2027)
    Table 10. Prostate-specific Antigen (PSA) Testing Market Trends
    Table 11. Prostate-specific Antigen (PSA) Testing Market Drivers
    Table 12. Prostate-specific Antigen (PSA) Testing Market Challenges
    Table 13. Prostate-specific Antigen (PSA) Testing Market Restraints
    Table 14. Global Prostate-specific Antigen (PSA) Testing Revenue by Players (2016-2021) & (US$ Million)
    Table 15. Global Prostate-specific Antigen (PSA) Testing Market Share by Players (2016-2021)
    Table 16. Global Top Prostate-specific Antigen (PSA) Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate-specific Antigen (PSA) Testing as of 2020)
    Table 17. Ranking of Global Top Prostate-specific Antigen (PSA) Testing Companies by Revenue (US$ Million) in 2020
    Table 18. Global 5 Largest Players Market Share by Prostate-specific Antigen (PSA) Testing Revenue (CR5 and HHI) & (2016-2021)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Prostate-specific Antigen (PSA) Testing Product Solution and Service
    Table 21. Date of Enter into Prostate-specific Antigen (PSA) Testing Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Prostate-specific Antigen (PSA) Testing Market Size by Type (2016-2021) (US$ Million)
    Table 24. Global Prostate-specific Antigen (PSA) Testing Revenue Market Share by Type (2016-2021)
    Table 25. Global Prostate-specific Antigen (PSA) Testing Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 26. Global Prostate-specific Antigen (PSA) Testing Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 27. Global Prostate-specific Antigen (PSA) Testing Market Size Share by Application (2016-2021) & (US$ Million)
    Table 28. Global Prostate-specific Antigen (PSA) Testing Revenue Market Share by Application (2016-2021)
    Table 29. Global Prostate-specific Antigen (PSA) Testing Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 30. Global Prostate-specific Antigen (PSA) Testing Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 31. North America Prostate-specific Antigen (PSA) Testing Market Size by Type (2016-2021) (US$ Million)
    Table 32. North America Prostate-specific Antigen (PSA) Testing Market Size by Type (2022-2027) & (US$ Million)
    Table 33. North America Prostate-specific Antigen (PSA) Testing Market Size by Application (2016-2021) (US$ Million)
    Table 34. North America Prostate-specific Antigen (PSA) Testing Market Size by Application (2022-2027) & (US$ Million)
    Table 35. North America Prostate-specific Antigen (PSA) Testing Market Size by Country (2016-2021) & (US$ Million) 
    Table 36. North America Prostate-specific Antigen (PSA) Testing Market Size by Country (2022-2027) & (US$ Million) 
    Table 37. Europe Prostate-specific Antigen (PSA) Testing Market Size by Type (2016-2021) (US$ Million)
    Table 38. Europe Prostate-specific Antigen (PSA) Testing Market Size by Type (2022-2027) & (US$ Million)
    Table 39. Europe Prostate-specific Antigen (PSA) Testing Market Size by Application (2016-2021) (US$ Million)
    Table 40. Europe Prostate-specific Antigen (PSA) Testing Market Size by Application (2022-2027) & (US$ Million)
    Table 41. Europe Prostate-specific Antigen (PSA) Testing Market Size by Country (2016-2021) & (US$ Million) 
    Table 42. Europe Prostate-specific Antigen (PSA) Testing Market Size by Country (2022-2027) & (US$ Million) 
    Table 43. Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Size by Type (2016-2021) (US$ Million)
    Table 44. Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Size by Type (2022-2027) & (US$ Million)
    Table 45. Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Size by Application (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Size by Application (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Size by Region (2016-2021) & (US$ Million) 
    Table 48. Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Size by Region (2022-2027) & (US$ Million) 
    Table 49. Latin America Prostate-specific Antigen (PSA) Testing Market Size by Type (2016-2021) (US$ Million)
    Table 50. Latin America Prostate-specific Antigen (PSA) Testing Market Size by Type (2022-2027) & (US$ Million)
    Table 51. Latin America Prostate-specific Antigen (PSA) Testing Market Size by Application (2016-2021) (US$ Million)
    Table 52. Latin America Prostate-specific Antigen (PSA) Testing Market Size by Application (2022-2027) & (US$ Million)
    Table 53. Latin America Prostate-specific Antigen (PSA) Testing Market Size by Country (2016-2021) & (US$ Million) 
    Table 54. Latin America Prostate-specific Antigen (PSA) Testing Market Size by Country (2022-2027) & (US$ Million) 
    Table 55. Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size by Type (2016-2021) (US$ Million)
    Table 56. Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size by Type (2022-2027) & (US$ Million)
    Table 57. Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size by Application (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size by Application (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size by Country (2016-2021) & (US$ Million) 
    Table 60. Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size by Country (2022-2027) & (US$ Million) 
    Table 61. Abbott Company Details
    Table 62. Abbott Business Overview
    Table 63. Abbott Prostate-specific Antigen (PSA) Testing Product
    Table 64. Abbott Revenue in Prostate-specific Antigen (PSA) Testing Business (2016-2021) & (US$ Million)
    Table 65. Abbott Recent Development
    Table 66. Boston Scientific Corporation Company Details
    Table 67. Boston Scientific Corporation Business Overview
    Table 68. Boston Scientific Corporation Prostate-specific Antigen (PSA) Testing Product
    Table 69. Boston Scientific Corporation Revenue in Prostate-specific Antigen (PSA) Testing Business (2016-2021) & (US$ Million)
    Table 70. Boston Scientific Corporation Recent Development
    Table 71. Bayer AG Company Details
    Table 72. Bayer AG Business Overview
    Table 73. Bayer AG Prostate-specific Antigen (PSA) Testing Product
    Table 74. Bayer AG Revenue in Prostate-specific Antigen (PSA) Testing Business (2016-2021) & (US$ Million)
    Table 75. Bayer AG Recent Development
    Table 76. Siemens Healthcare Company Details
    Table 77. Siemens Healthcare Business Overview
    Table 78. Siemens Healthcare Prostate-specific Antigen (PSA) Testing Product
    Table 79. Siemens Healthcare Revenue in Prostate-specific Antigen (PSA) Testing Business (2016-2021) & (US$ Million)
    Table 80. Siemens Healthcare Recent Development
    Table 81. DiaSorin Company Details
    Table 82. DiaSorin Business Overview
    Table 83. DiaSorin Prostate-specific Antigen (PSA) Testing Product
    Table 84. DiaSorin Revenue in Prostate-specific Antigen (PSA) Testing Business (2016-2021) & (US$ Million)
    Table 85. DiaSorin Recent Development
    Table 86. Roche Company Details
    Table 87. Roche Business Overview
    Table 88. Roche Prostate-specific Antigen (PSA) Testing Product
    Table 89. Roche Revenue in Prostate-specific Antigen (PSA) Testing Business (2016-2021) & (US$ Million)
    Table 90. Roche Recent Development
    Table 91. Beckman Coulter Company Details
    Table 92. Beckman Coulter Business Overview
    Table 93. Beckman Coulter Prostate-specific Antigen (PSA) Testing Product
    Table 94. Beckman Coulter Revenue in Prostate-specific Antigen (PSA) Testing Business (2016-2021) & (US$ Million)
    Table 95. Beckman Coulter Recent Development
    Table 96. PerkinElmer Company Details
    Table 97. PerkinElmer Business Overview
    Table 98. PerkinElmer Revenue in Prostate-specific Antigen (PSA) Testing Business (2016-2021) & (US$ Million)
    Table 99. PerkinElmer Recent Development
    Table 100. Tosoh Company Details
    Table 101. Tosoh Business Overview
    Table 102. Tosoh Prostate-specific Antigen (PSA) Testing Product
    Table 103. Tosoh Revenue in Prostate-specific Antigen (PSA) Testing Business (2016-2021) & (US$ Million)
    Table 104. Tosoh Recent Development
    Table 105. Ortho Clinical Company Details
    Table 106. Ortho Clinical Business Overview
    Table 107. Ortho Clinical Prostate-specific Antigen (PSA) Testing Product
    Table 108. Ortho Clinical Revenue in Prostate-specific Antigen (PSA) Testing Business (2016-2021) & (US$ Million)
    Table 109. Ortho Clinical Recent Development
    Table 110. Fujirebio Company Details
    Table 111. Fujirebio Business Overview
    Table 112. Fujirebio Prostate-specific Antigen (PSA) Testing Product
    Table 113. Fujirebio Revenue in Prostate-specific Antigen (PSA) Testing Business (2016-2021) & (US$ Million)
    Table 114. Fujirebio Recent Development
    Table 115. Mediwatch Company Details
    Table 116. Mediwatch Business Overview
    Table 117. Mediwatch Prostate-specific Antigen (PSA) Testing Product
    Table 118. Mediwatch Revenue in Prostate-specific Antigen (PSA) Testing Business (2016-2021) & (US$ Million)
    Table 119. Mediwatch Recent Development
    Table 120. BodiTech Company Details
    Table 121. BodiTech Business Overview
    Table 122. BodiTech Prostate-specific Antigen (PSA) Testing Product
    Table 123. BodiTech Revenue in Prostate-specific Antigen (PSA) Testing Business (2016-2021) & (US$ Million)
    Table 124. BodiTech Recent Development
    Table 125. Bristol-Myers Squibb Company Company Details
    Table 126. Bristol-Myers Squibb Company Business Overview
    Table 127. Bristol-Myers Squibb Company Prostate-specific Antigen (PSA) Testing Product
    Table 128. Bristol-Myers Squibb Company Revenue in Prostate-specific Antigen (PSA) Testing Business (2016-2021) & (US$ Million)
    Table 129. Bristol-Myers Squibb Company Recent Development
    Table 130. GE Healthcare Company Details
    Table 131. GE Healthcare Business Overview
    Table 132. GE Healthcare Prostate-specific Antigen (PSA) Testing Product
    Table 133. GE Healthcare Revenue in Prostate-specific Antigen (PSA) Testing Business (2016-2021) & (US$ Million)
    Table 134. GE Healthcare Recent Development
    Table 135. Endocare Company Details
    Table 136. Endocare Business Overview
    Table 137. Endocare Prostate-specific Antigen (PSA) Testing Product
    Table 138. Endocare Revenue in Prostate-specific Antigen (PSA) Testing Business (2016-2021) & (US$ Million)
    Table 139. Endocare Recent Development
    Table 140. Merck＆Co. Company Details
    Table 141. Merck＆Co. Business Overview
    Table 142. Merck＆Co. Prostate-specific Antigen (PSA) Testing Product
    Table 143. Merck＆Co. Revenue in Prostate-specific Antigen (PSA) Testing Business (2016-2021) & (US$ Million)
    Table 144. Merck＆Co. Recent Development
    Table 145. Medtronic Company Details
    Table 146. Medtronic Business Overview
    Table 147. Medtronic Prostate-specific Antigen (PSA) Testing Product
    Table 148. Medtronic Revenue in Prostate-specific Antigen (PSA) Testing Business (2016-2021) & (US$ Million)
    Table 149. Medtronic Recent Development
    Table 150. Sanofi-Aventis SA Company Details
    Table 151. Sanofi-Aventis SA Business Overview
    Table 152. Sanofi-Aventis SA Prostate-specific Antigen (PSA) Testing Product
    Table 153. Sanofi-Aventis SA Revenue in Prostate-specific Antigen (PSA) Testing Business (2016-2021) & (US$ Million)
    Table 154. Sanofi-Aventis SA Recent Development
    Table 155. Research Programs/Design for This Report
    Table 156. Key Data Information from Secondary Sources
    Table 157. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Prostate-specific Antigen (PSA) Testing Market Share by Type: 2020 VS 2027
    Figure 2. CLIA Method Features
    Figure 3. ELISA Method Features
    Figure 4. Global Prostate-specific Antigen (PSA) Testing Market Share by Application: 2020 VS 2027
    Figure 5. Screening Case Studies
    Figure 6. Post-treatment Monitoring Case Studies
    Figure 7. Other Case Studies
    Figure 8. Prostate-specific Antigen (PSA) Testing Report Years Considered
    Figure 9. Global Prostate-specific Antigen (PSA) Testing Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 10. Global Prostate-specific Antigen (PSA) Testing Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 11. Global Prostate-specific Antigen (PSA) Testing Market Share by Regions: 2020 VS 2027
    Figure 12. Global Prostate-specific Antigen (PSA) Testing Market Share by Regions (2022-2027)
    Figure 13. Global Prostate-specific Antigen (PSA) Testing Market Share by Players in 2020
    Figure 14. Global Top Prostate-specific Antigen (PSA) Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate-specific Antigen (PSA) Testing as of 2020
    Figure 15. The Top 10 and 5 Players Market Share by Prostate-specific Antigen (PSA) Testing Revenue in 2020
    Figure 16. Global Prostate-specific Antigen (PSA) Testing Revenue Market Share by Type (2016-2021)
    Figure 17. Global Prostate-specific Antigen (PSA) Testing Revenue Market Share by Type (2022-2027)
    Figure 18. North America Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 19. North America Prostate-specific Antigen (PSA) Testing Market Share by Type (2016-2027)
    Figure 20. North America Prostate-specific Antigen (PSA) Testing Market Share by Application (2016-2027)
    Figure 21. North America Prostate-specific Antigen (PSA) Testing Market Share by Country (2016-2027)
    Figure 22. United States Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 23. Canada Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Europe Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Europe Prostate-specific Antigen (PSA) Testing Market Share by Type (2016-2027)
    Figure 26. Europe Prostate-specific Antigen (PSA) Testing Market Share by Application (2016-2027)
    Figure 27. Europe Prostate-specific Antigen (PSA) Testing Market Share by Country (2016-2027)
    Figure 28. Germany Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. France Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. U.K. Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. Italy Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Russia Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Nordic Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Share by Type (2016-2027)
    Figure 36. Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Share by Application (2016-2027)
    Figure 37. Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Share by Region (2016-2027)
    Figure 38. China Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Japan Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. South Korea Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Southeast Asia Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. India Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Australia Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Latin America Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Latin America Prostate-specific Antigen (PSA) Testing Market Share by Type (2016-2027)
    Figure 46. Latin America Prostate-specific Antigen (PSA) Testing Market Share by Application (2016-2027)
    Figure 47. Latin America Prostate-specific Antigen (PSA) Testing Market Share by Country (2016-2027)
    Figure 48. Mexico Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Brazil Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Share by Type (2016-2027)
    Figure 52. Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Share by Application (2016-2027)
    Figure 53. Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Share by Country (2016-2027)
    Figure 54. Turkey Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. Saudi Arabia Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. UAE Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Abbott Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2016-2021)
    Figure 58. Boston Scientific Corporation Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2016-2021)
    Figure 59. Bayer AG Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2016-2021)
    Figure 60. Siemens Healthcare Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2016-2021)
    Figure 61. DiaSorin Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2016-2021)
    Figure 62. Roche Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2016-2021)
    Figure 63. Beckman Coulter Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2016-2021)
    Figure 64. PerkinElmer Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2016-2021)
    Figure 65. Tosoh Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2016-2021)
    Figure 66. Ortho Clinical Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2016-2021)
    Figure 67. Fujirebio Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2016-2021)
    Figure 68. Mediwatch Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2016-2021)
    Figure 69. BodiTech Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2016-2021)
    Figure 70. Bristol-Myers Squibb Company Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2016-2021)
    Figure 71. GE Healthcare Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2016-2021)
    Figure 72. Endocare Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2016-2021)
    Figure 73. Merck＆Co. Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2016-2021)
    Figure 74. Medtronic Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2016-2021)
    Figure 75. Sanofi-Aventis SA Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2016-2021)
    Figure 76. Bottom-up and Top-down Approaches for This Report
    Figure 77. Data Triangulation
    Figure 78. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Abbott
Boston Scientific Corporation
Bayer AG
Siemens Healthcare
DiaSorin
Roche
Beckman Coulter
PerkinElmer
Tosoh
Ortho Clinical
Fujirebio
Mediwatch
BodiTech
Bristol-Myers Squibb Company
GE Healthcare
Endocare
Merck＆Co.
Medtronic
Sanofi-Aventis SA

Frequently Asked Questions

What is the USP of the report? expand_more
Prostate-specific Antigen (PSA) Testing report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
What are the key content of the report? expand_more
Prostate-specific Antigen (PSA) Testing report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
What are the value propositions and opportunities offered in this market research report? expand_more
Prostate-specific Antigen (PSA) Testing report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.